Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. WuXi Biologics (Cayman) Inc.
  6. News
  7. Summary
    2269   KYG970081173

WUXI BIOLOGICS (CAYMAN) INC.

(2269)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Hong Kong shares close 0.6% higher as tech and financial stocks gain

10/08/2021 | 04:47am EST

Oct 8 (Reuters) - Hong Kong shares finished 0.6% higher on Friday, led by tech and financial stocks amid easing political tensions between China and the United States.

Tracking gains made overnight on Wall Street, the Hang Seng index rose to 24,837.85, while the China Enterprises Index climbed 0.7% to 8,775.65.

** The U.S. and China have agreed in principle for their presidents to hold a virtual meeting before the year's end.

** The information technology subindex rose 2.2%.

** Index heavyweight Alibaba Group jumped 5.6%, the biggest daily gainer on the city's benchmark.

** Internet giants Tencent Holdings and Meituan added more than 2% each.

** The financials subindex ended 0.4% higher, with China Life Insurance Co and Ping An Insurance Group climbing 4.2% and 2.8% respectively.

** WuXi Biologics Inc and Li Ning Co fell more than 5.8% each.

** The healthcare subindex, the energy subindex , the industrial subindex, and utility subindex logged declines of between 1.5% and 3%. (Reporting by the Shanghai Newsroom; Editing by Edwina Gibbs)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
LI NING COMPANY LIMITED -3.43% 84.45 End-of-day quote.58.44%
MEITUAN -3.65% 232.4 End-of-day quote.-21.11%
TENCENT HOLDINGS LIMITED -3.20% 447.8 End-of-day quote.-20.60%
WUXI BIOLOGICS (CAYMAN) INC. -7.07% 95.9 End-of-day quote.-6.71%
All news about WUXI BIOLOGICS (CAYMAN) INC.
12/02EMA - Increase in manufacturing capacity for COVID-19 vaccine from AstraZeneca
AQ
11/30CANbridge Pharmaceuticals Secures WuXi Biologics Backing for $88 Million Hong Kong IPO
MT
11/23WUXI BIOLOGICS CAYMAN : First GMP Production at 24,000L Line of MFG5 Facility Successfully..
PU
11/22WuXi Biologics Announces Completion of GMP Production At 24,000L Line of Its Drug Subst..
CI
11/09Hong Kong shares close higher as healthcare stocks rebound
RE
11/09Shanghai stocks flat as new lending tool fails to excite investors
RE
11/02Wuxi Biologics CFO Retires; Co-CFO to Take Over
MT
11/01WuXi Biologics Inc. Announces Chief Financial Officer Changes
CI
11/01Hong Kong shares close lower as tech, healthcare stocks weigh
RE
10/31China's blue-chip shares fall on hit from recent COVID-19 outbreaks
RE
More news
Analyst Recommendations on WUXI BIOLOGICS (CAYMAN) INC.
More recommendations
Financials
Sales 2021 9 711 M 1 523 M 1 523 M
Net income 2021 3 025 M 474 M 474 M
Net cash 2021 5 818 M 912 M 912 M
P/E ratio 2021 133x
Yield 2021 -
Capitalization 407 B 52 233 M 63 839 M
EV / Sales 2021 41,3x
EV / Sales 2022 28,0x
Nbr of Employees 7 686
Free-Float 84,4%
Chart WUXI BIOLOGICS (CAYMAN) INC.
Duration : Period :
WuXi Biologics (Cayman) Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WUXI BIOLOGICS (CAYMAN) INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 95,90 CNY
Average target price 129,52 CNY
Spread / Average Target 35,1%
EPS Revisions
Managers and Directors
Zhi Sheng Chen Chief Executive Officer & Executive Director
Ming Tu Chief Financial Officer & Executive Vice President
Ge Li Non-Executive Chairman
Weichang Zhou Executive Director, Chief Technology Officer & EVP
William Robert Keller Independent Non-Executive Director
Sector and Competitors